Dutch Judges To Decide Whether Humira’s Price And AbbVie’s Profits Are “Too High”

Press/Media: Research

Period1 Mar 2023

Media contributions

1

Media contributions

Keywords

  • excessive pricing
  • pharmaceutical companies